行情

RLM

RLM

Realm Therapeutics
NASDAQ

实时行情|Nasdaq Last Sale

2.500
-0.010
-0.40%
已退市 16:00 07/30 EDT
开盘
2.560
昨收
2.510
最高
2.760
最低
2.450
成交量
9.40万
成交额
--
52周最高
13.00
52周最低
1.350
市值
--
市盈率(TTM)
--
分时
5日
1月
3月
1年
5年

RLM 新闻

  • 绝不延迟脱欧 英首相自比"绿巨人":越疯狂,就越强大
  • 环球网.1小时前
  • 沙特石油设施遇袭产量减半 美随时准备动用石油储备
  • 新京报网.2小时前
  • 新华国际时评:央行“放水”恐难纾欧元区之困
  • 新华网.2小时前
  • 沙特官员:周一石油产量将恢复到正常水平
  • 新浪美股.3小时前

更多

热门股票

名称
价格
涨跌幅

RLM 简况

Realm Therapeutics plc, formerly PuriCore plc, is a biopharmaceutical company. The Company is focused on leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company has initiated drug development programs based on its hypochlorous acid technology. The Company is engaged in the development of small molecule therapies with potential application for the treatment of diseases in a number of therapeutic areas, and an initial focus in dermatology and ophthalmology. The Company has developed proprietary formulations of its technology, with anti-inflammatory and immunomodulatory benefits. Its pipeline of products include PR013 and PR022, which are in Phase I. PR013 is indicated for allergic conjunctivitis and PR022 is indicated for atopic dermatitis. Realm Therapeutics, Inc. is a subsidiary of the Company.
展开

Webull提供Realm Therapeutics PLC 的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。